Cytek Biosciences Inc (CTKB) returns
Cytek Biosciences returns over 5 years
$1,000 invested in Cytek Biosciences five years ago was worth $268.74 at the close on October 30, 2026, with dividends reinvested: an average return of -23.1% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +2.9% | — | $1,029 | -0.9% |
| 3 months | +42.2% | — | $1,422 | +2.1% |
| Year to date | +21.4% | — | $1,214 | +11.7% |
| 1 year | +60.5% | — | $1,605 | +12.4% |
| 3 years | +49.5% | +14.3% | $1,495 | +88.5% |
| 5 years | -73.1% | -23.1% | $268.74 | +76.0% |
Cytek Biosciences return by calendar year
| Year | CTKB | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +21.4% | +11.7% | +9.7% |
| 2025 | -22.2% | +17.7% | -39.9% |
| 2024 | -28.8% | +24.9% | -53.7% |
| 2023 | -10.7% | +26.2% | -36.9% |
| 2022 | -37.4% | -18.2% | -19.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: CTKB financials
No forecast, no recommendation. This page describes Cytek Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.